Phibro Animal Health

PAHC

Market cap $1.48B

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals. This agreement grants Phibro exclusive rights to develop, manufacture, and commercialize Lighthouse Pharma's proprietary compound for canine periodontal care. The compound represents a promisin.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.

ALHC, STNE, EGAN, PAHC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on October 7, 2025.

MTG, PAHC and ICAGY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 7, 2025.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

UGP, PDS, FUTU, PAHC and PGY have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2025.

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.